6:08 PM
 | 
Sep 27, 2007
 |  BC Extra  |  Top Story

CHMP proposes amending ESA labels

Amgen (AMGN) said that EMEA's CHMP proposed to amend the EU prescribing information for erythropoiesis-stimulating agents (ESAs), including AMGN's Aranesp darbepoetin alfa. The agency's proposal includes stipulating a uniform target hemoglobin range for all epoetins of 10-12 g/dL. Aranesp's label...

Read the full 190 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >